IDEAYA Biosciences (IDYA) Profit After Tax (2018 - 2026)

IDEAYA Biosciences has reported Profit After Tax for 9 years, with the latest figure at -$98.5 million in Q1 2026.

• Quarterly Profit After Tax fell 38.0% year-over-year to -$98.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$140.8 million (up 54.57% YoY) and the FY2025 annual result came in at -$113.7 million, up 58.54% from the prior year.
• Profit After Tax declined to -$98.5 million in Q1 2026 per IDYA's latest filing, from -$84.5 million in the prior quarter.
• Over five years, Profit After Tax peaked at $119.8 million in Q3 2025 and troughed at -$133.3 million in Q4 2024.
• A 5-year average of -$38.7 million and a median of -$34.0 million in 2023 frame the typical range for Profit After Tax.
• The sharpest annual moves came in 2023 and 2025: Profit After Tax sank 2309.34% in 2023, then jumped 331.13% in 2025.
• Over 5 years, Profit After Tax stood at -$20.9 million in 2022, then sank by 62.38% to -$34.0 million in 2023, then slumped by 292.68% to -$133.3 million in 2024, then surged by 36.62% to -$84.5 million in 2025, then dropped by 16.6% to -$98.5 million in 2026.
• According to Business Quant data, Profit After Tax over the past three periods registered -$98.5 million, -$84.5 million, and $119.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.